The use of central venous catheters, while advantageous, is associated with a range of complications including thrombosis and infection. These complications can pose significant physical and financial costs to the patient and health care system. A critical appraisal of the two randomized controlled trials examining this topic in critically ill patients has shown that heparin-bonded central venous catheters significantly reduced the incidence of catheter-related thrombosis and infection in children and adults. These findings suggest that heparin-bonded central venous catheters should be considered for routine use in critically ill patients.
Krafte-JacobsB., SivitC.J., MejiaR., PollackM.M.Catheter-related thrombosis in critically ill children: comparison of catheters with and without heparin bonding.J Pediatr1995; 126: 50–54.
2.
PierceC.M., WadeA., MokQ.Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children.Intensive Care Med2000; 26: 967–972.
3.
AppelgrenP., RansjoU., BindslevL., EspersenF., LarmO.Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: results from a prospective, randomized trial.Crit Care Med1996; 24: 1482–1489.
4.
LasterJ.L., NicholsW.K., SilverD.Thrombocytopenia associated with heparin-coated catheters in patients with heparin-associated antiplatelet antibodies.Arch Intern Med1989; 149: 2285–2287.
5.
LeonC., Ruiz-SantanaS., RelloJ.Benefits of minocycline and rifampin-impregnated central venous catheters. A prospective, randomized, double-blind, controlled, multicenter trial.Intensive Care Med2004; 30: 1891–1899.
